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Abstract
Background: The aim of this study is to examine how clinicians and patients negotiate clinical
need and treatment decisions within a context of finite resources. Dental implant treatment is an
effective treatment for missing teeth, but is only available via the NHS in some specific clinical
circumstances. The majority of people who receive this treatment therefore pay privately, often at
substantial cost to themselves. People are used to paying towards dental treatment costs.
However, dental implant treatment is much more expensive than existing treatments – such as
removable dentures. We know very little about how dentists make decisions about whether to
offer such treatments, or what patients consider when deciding whether or not to pay for them.
Methods/Design: Mixed methods will be employed to provide insight and understanding into
how clinical need is determined, and what influences people's decision making processes when
deciding whether or not to pursue a dental implant treatment. Phase 1 will use a structured scoping
questionnaire with all the General dental practitioners (GDPs) in three Primary Care Trust areas
(n = 300) to provide base-line data about existing practice in relation to dental implant treatment,
and to provide data to develop a systematic sampling procedure for Phase 2. Phases 2 (GDPs) and
3 (patients) use qualitative focused one to one interviews with a sample of these practitioners (up
to 30) and their patients (up to 60) to examine their views and experiences of decision making in
relation to dental implant treatment. Purposive sampling for phases 2 and 3 will be carried out to
ensure participants represent a range of socio-economic circumstances, and choices made.
Discussion: Most dental implant treatment is conducted in primary care. Very little information
was available prior to this study about the quantity and type of treatment carried out privately. It
became apparent during phase 2 that ISOD treatment was an unusual treatment in primary care.
We thus extended our sample criteria for Phase 3 to include people who had had other implant
supported restorations, although not single tooth replacements.
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In the UK, and other western societies, people are living
longer lives with less acute infectious disease, but experi-
encing more long term degenerative conditions in later
life. As a result, medical care is increasingly being focussed
on managing chronic illness, rather than curative treat-
ment; improving and maintaining quality of life is a key
concern for health care provision. Further, ongoing medi-
cal and technological advances offer increasing possibili-
ties for maintenance of health and quality of life.
Although recent political debate has emphasised the need
for the increased use of technologies in the delivery of
health care services[1,2], this must be considered within a
context of a growing proportion of the population that
might benefit from such treatments. This presents a prob-
lem for those responsible for delivering health care in a
context of finite resources, and decisions must be made
about how such resources should be allocated [3]. In
health care systems, like the NHS, which are based on the
premise that health care should be free at the point of
delivery, identifying ways of balancing the supply and
demand of finite resources is becoming increasingly nec-
essary [4].
One mechanism of addressing finite resources is for
patients to pay a contribution towards the cost of their
treatment. Within this particular model of providing and
financing health care it is useful to understand how clini-
cal need and treatment decisions are negotiated. This is
necessary for three reasons: Firstly, any rationing of serv-
ices impacts on the everyday practice of health care profes-
sionals who must make decisions about the provision of
services to individual patients using criteria which are
beyond perceived clinical need, thereby according greater
significance to non-clinical influences on decision-mak-
ing [5]. Secondly, patients themselves are faced with addi-
tional choices and decisions to make about treatments
and services offered to them. They not only need to con-
sider their perceived clinical need, but also any potential
benefits to their quality of life, as well as assessing the
value of such benefits if they as individual patients are
required to make a part or whole contribution. Thirdly,
resource rationing, and the increasing consideration
required of non-medical decision making factors, has
important implications for how clinical need itself gets
negotiated and reconfigured through the process of deci-
sion-making.
This study will use the provision of complete implant-
supported overdentures (ISOD) as the vehicle to develop
generically applicable insights into the processes of nego-
tiating clinical need and making treatment decisions
within a context of rationed resources. Implants are
devices that can be placed directly into the bone of the
jaws to replace lost teeth and/or provide support for den-
tures. They are highly effective as they stabilize the denture
and allow much improved function. ISODs have been
shown to improve patient satisfaction and edentulous
patients' oral related quality of life in this clinical situation
which can be regarded as a chronic disability or handicap
[6-8]. The physical impairment brought about by the loss
of natural teeth represents a chronic disability because it
negatively impacts on daily living activities, such as eating
and speaking. A proportion of denture wearers may also
be considered to be handicapped as they will actually
avoid performing such activities in front of anyone out-
side close family members [9,10]. ISODs are currently
only available without charge through referral to second-
ary care. However, this option is only available to a very
small proportion of these patients with very specific clini-
cal needs. Within primary care dentistry, however, indi-
viduals are increasingly being able to choose implant
treatment for which they incur a personal financial cost.
Therefore this provides an excellent clinical setting which
is constrained by finite resources in which to examine the
process of patients and clinicians negotiating clinical need
and treatment decisions.
Current evidence suggests that most edentulous patients
would benefit from ISODs, and this form of treatment has
been proposed by the McGill Consensus as the minimal
standard of care [8], however, there are not enough
resources available to enable this. Within the current con-
text there are two main groups who qualify for the provi-
sion of ISOD without incurring a personal financial cost
within secondary care. The first is patients with severe
denture intolerance including severe resorption of the
lower jaw. These patients would normally be referred
from their GDPs or from within the hospital. The second
group comprises patients with apparently satisfactory
anatomy but who find it more difficult than most to adapt
to the limitations of complete dentures. Although it
would be expected that secondary care provides implant
treatment for those with the most marked problems, this
is not necessarily the case. Those who receive such treat-
ments may do so because of there being no available pro-
vision of ISODs within primary care in their locality, the
referral patterns of their GDP or because they are more
persistent in seeking a solution for their problems. Simi-
larly, within primary care personal clinical experience sug-
gests that people from a range of socio-economic
backgrounds are willing to pay for ISOD.
Whilst the barriers to providing ISODs are not clear, they
are likely to include the fact that, although an increasing
number of GDPs have training and experience to carry out
implant procedures, only a minority choose to do so.
Compounding this issue is the fact that people now main-
tain natural teeth much longer, with the resultant effect
being that the age at which people may become edentu-Page 2 of 8
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ing to dentures even more difficult and thus experience
more problems which would be ameliorated by implants.
Thus, the disparity between resources and demand for
treatment services is increasing, and therefore a greater
understanding of the processes of decision-making
around treatment such as these that have personal cost
implications, from the perspectives of both patients and
dentists is required.
Finite health care resources have implications for practi-
tioners and patients and also for how clinical need is
determined and negotiated. Practitioners draw on a range
of 'non-medical' factors in making decisions about how to
treat their patients [5,11]. Broadly, such factors have been
characterised as relating to characteristics of the patient;
characteristics of the clinician; and features of the practice
setting[5]. Demographic, socio-economic and social fac-
tors are known to be important in influencing treatment
decisions made by health professionals. However, it has
not yet been investigated how professionals' approaches
to treatment decision-making may be affected by situa-
tions where the treatment option may incur personal
financial costs for the patient. Limited existing research
suggests that professionals themselves may adopt various
strategies, including concentrating their discussions about
possible treatments on those who are perceived to be able
to afford to pay [3]. Given the link between low-income
and ill-health, this is unlikely to be a strategy which will
meet all patient need and, indeed, may increase inequali-
ties in health and access to health services[3]. Questions
also exist concerning how professionals make judgements
and decisions about referrals to scarce secondary care
resources, and what treatment options and choices to
offer to which patients. In the context of dentistry, the day
to day decisions made by GDPs have a significant influ-
ence on the oral health of the population [12]. Whilst
much previous research has concentrated on the influence
of clinical factors on treatment decisions, it is increasingly
acknowledged that factors such as the financial environ-
ment and patients' preferences might be expected to exert
a major influence on dentists' decision making practices
but are, as yet, poorly understood [13,14]. In relation to
ISODs, limited work in the area suggests that the relative
influence of a range of factors (oral, medical and per-
sonal) on decision-making appears to vary greatly
between different practitioner groups [15]; this requires
further investigation. Understanding the process by which
health professionals, including dentists, make treatment
decisions is becoming increasingly relevant in the context
of increasing expectations of evidence based practice. Not
only is it essential for dentists to consider the patient's val-
ues for alternative treatments and outcomes [16] but it is
also argued that dentists should combine the patient's
treatment needs and preferences with the best available
scientific evidence in conjunction with their own clinical
expertise [17,18].
As well as considering the implications for clinicians it is
also important to note that the involvement and partici-
pation of patients, and the public generally, in decision-
making about health care is a key priority in health policy
[19,20], which has attracted a substantive body of empir-
ical research [21]. Patients, and their roles in decision-
making, have been conceptualised in various ways rang-
ing from 'self-managers' [22] to an increasing emphasis
on the patient as a 'customer' [23]. In reality however,
such roles for patients are rarely realised [24] and indeed
patients may choose to adopt different 'roles' at different
points within and without the clinical encounter. Clearly,
in a health provision context where demand for services is
increasing and resources are limited, patients themselves
will be increasingly required to make decisions about
treatments that involve additional personal costs to them-
selves, and which might bring considerable improvement
to their quality of life and/or self esteem. Patient partici-
pation in decisions about dental treatments is beginning
to attract empirical attention. Initial findings indicate that
dental patients do have distinct preferences in relation to
decision-making roles, and that these may not always be
met in their interactions with their dentists [25].
When making treatment decisions clinicians and patients
must first determine clinical need. It is well recognised
that social factors are particularly pertinent to practi-
tioner-patient consultations [26]. In dentistry, it is
acknowledged that economic constraints may present
problems for the definition and assessment of clinical
need [27]. It is argued that the assessment of need, and
decision-making processes, should be considered on the
three levels of the patient, dentists, and society. A key chal-
lenge for decision making around need in the context of
dentistry is to establish the legitimate roles of these vari-
ous parties, so that the concept of need can be used as a
basis for planning and provision of services. Such goals
would be advanced through a better understanding of
how clinical need is defined and assessed by both patients
and practitioners in decisions concerning treatments that
have personal cost implications.
The benefits of a clearer understanding of negotiating clin-
ical need and treatment decisions within the context of
limited and finite resources is of interest to patients, pur-
chasers and providers of health care services. At a national
level, strategic planning and implementation of the deliv-
ery of a National Health Service is dependant on a full
understanding of issues such as the uptake of care for the
management of chronic conditions from the private sec-
tor. Those who commission the delivery of state funded
health and social care (through Primary Care and SocialPage 3 of 8
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health services that reflect an understanding of decision
making priorities and willingness to pay on the part of
those who use them. Service providers (practitioners)
themselves need to understand the complex, hitherto
unexplored relationship between payment, effectiveness
of treatment and demand in a health service which is
increasingly a mix of public and privately funding. Those
who insure patients against the costs of private treatment
also have an interest in the process of decision making
where a financial commitment is required.
This multi-disciplinary study will provide generically
applicable and timely insights into an increasingly perti-
nent area of how clinical need and treatment decisions are
negotiated within a context of finite resources. It will
address this issue by examining in detail how, in a health
care system with finite resources, clinical need and treat-
ment decisions are mediated by perceived costs: physical,
social, psychological and financial. Further, by addressing
this neglected area of clinical research of interactions
within dental consultations, it will develop new insights
and understandings of the decision-making process
within dentistry.
Aims and objectives
The aim of this study is to examine how clinicians and
patients negotiate clinical need and treatment decisions
within a context of finite resources.
This study will develop understandings of how both
health professionals and patients negotiate clinical need
and make decisions about treatment options. In particular
it will examine how interpretations of need and subse-
quent decisions about treatment are mediated by social
and psychological factors, as well as the financial environ-
ment in which such joint decision making takes place.
Specifically it will:
1. Examine how notions of clinical need are negotiated by
both patients and health professionals,
2. Critically investigate the relationship between con-
structs of clinical need and treatment decisions,
3. Assess the relative influences of professional, physical-
ity (symptoms and/or aesthetics), social and psychologi-
cal factors on patients' decision making processes, and
4. Compare and contrast the ways in which patients' deci-
sion making processes may change when they incur a per-
sonal financial cost.
Methods
In order to begin to understand this under-researched area
this project will take an inductive approach to examine in
detail both practitioners' and patients' experiences. Mixed
methods will be employed to provide insight and under-
standing into how clinical need is determined, and what
influences people's decision making processes when
deciding to pursue a particular course of treatment. Phase
1 will use a structured scoping questionnaire to provide
base-line data about existing practice. Phases 2 and 3 will
both use qualitative focused interviews with practitioners
and patients to examine their views and experiences.
Focused interviews are a particularly useful tool to employ
in an area where relatively little is known about the ways
in which people make decisions. They are flexible enough
to allow interviewer and interviewee to explore issues
which are pertinent to the individual person which had
not been anticipated in advance, thus enabling a fuller
understanding of the processes at work to emerge. The
study comprises three inter-related phases:
Phase 1 – Establishing existing practice
The aims of Phase 1 are:
• To provide accurate data about the proportion of GDPs
offering implants as a treatment option
• To provide data to develop a systematic sampling proce-
dure for Phase 2
There are two potential treatments available to edentulous
patients: conventional dentures and ISOD. In order to
establish the relative influences on negotiating clinical
need and pursuing a particular treatment option, it is nec-
essary to identify those GDPs who do offer patients the
possibility of implant over dentures. Presently there are
no data providing us with this information. Sample: All
primary care dental practices across the North East Eng-
land Region (Newcastle upon Tyne, North Tyneside and
Northumbria) (n = 135 practices; 300 GDPs). Method: As
no existing questionnaire is available, a postal question-
naire will be designed and pre-tested with a panel of den-
tal practitioners. An introductory letter will be sent to all
GDPs explaining the nature of the research. This will be
followed 2 weeks later by a postal questionnaire with
instructions and a stamped addressed envelope for the
return of the questionnaire. Included with this will be an
information sheet relating to phases 2 and 3 and a form
asking for the practitioners consent to be contacted with a
view to further participation in the research. One
reminder will be sent four weeks after initial posting. Anal-
ysis: Data will be entered into a suitable software package
e.g. SPSS and simple descriptive statistical analysis will be
conducted. The data from these questionnaires will iden-
tify four groups of GDPs: 1) those who offer implant treat-Page 4 of 8
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who refer to other colleagues within primary care or sec-
ondary care (for which patients must pay); 3) those who
to refer to secondary care where a limited supply of
implants are available free of charge to patients with par-
ticular clinical needs; 4) those who do not offer implants
– conventional dentures only. These data serve two pur-
poses: 1) to describe current practice within the region; 2)
to provide the sampling frames for Phases 2 & 3 (see table
1 below).
Phase 2 – Practitioners' experiences
The aims of Phase 2 are:
• To determine how practitioners establish clinical need
for implants
• To determine the perceived physical, social, psychologi-
cal, financial factors which may affect whether implant
treatments is offered
• To determine from practitioners' accounts how implant
treatment is offered to patients
• To determine practitioners' views about why people
choose particular treatments
Sampling: The sample (up to 30) will include three groups
of GDPs: 1) those who offer implant treatment with a cost
to the patient within primary care; 2) those who refer to
others who offer implant treatment with a cost to the
patient within primary care 3) those who refer to second-
ary care with no cost to the patient (see table 1 below). A
purposive sample strategy will be used in order to ensure
that the full breadth of socio-economic practice settings
(rural: urban, deprived: affluent) is represented in the
sample. Method: Focused interviews will be conducted on
an individual basis with GDPs. Written informed consent
will be obtained at the time of but prior to the interview.
All interviews will be audio-recorded. Clinicians will be
paid for their time to take part in the interview.
Phase 3: Patients' experiences
The aims of Phase 3 are:
• To gather patients' accounts of how treatment options
were presented to them
• To examine patients' accounts of their care throughout
their treatment
• To determine the relative influence of social, psycholog-
ical, physical and financial factors on their treatment deci-
sion
• To compare the experiences of those who incurred a per-
sonal financial cost with those who did not
Sampling: Patients (up to 60) who have been offered
implant treatment in different settings will be recruited via
their practitioners in Phase 2 (or, where necessary, via sec-
ondary care). It is anticipated that there may be a relatively
small number of people going through implant treatment
at any one time, and coupled with issues of recruiting for
research studies, patient recruitment will take place both
retrospectively and prospectively. The sample will include
people who have very recently been offered implant treat-
ment as well as identifying those who were offered treat-
ment up to 12 months ago. We will recruit patients who
have chosen to pay for ISOD in primary care, those who
refused ISOD in primary care, and those who were offered
ISOD treatment, which incurred no personal financial
cost, in secondary care. This will identify 6 different
groups of patients who have been offered and either
accepted or refused treatment by: their own GDP, another
GDP, or secondary care (see table 1). A purposive sample
Table 1: Sampling and methods summary:
Phase 1: Screening questionnaire – All GDPs to identify:
Personally provide implant treatment Refer on Never offer
Refer within primary care Refer to Secondary
Phase 2: Interviews with GDPs about practice
Personally provide implant treatment Refer within primary care Refer to Secondary
To provide retrospective and prospective sample for Phase3
Phase 3: Interviews with patients retrospectively and prospectively
Offered treatment by another GDP Offered treatment by own GDP Referred to secondary care
Accept
Implants
Refuse
Implants
Accept
Implants
Refuse
Implants
Accept
Implants
Refuse
ImplantsPage 5 of 8
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breadth of socio-economic situations is represented in the
sample. Patients will be invited to opt-in to the study.
Although it is likely that patients and practitioners will be
recruited from the same practices, for ethical and method-
ological reasons it is not intended that these data will be
linked in any way for the purpose of questioning or anal-
ysis. This will allow us to preserve respondents' anonym-
ity thus encouraging open and honest responses as
necessary to examine the relative influences of different
factors on people's decisions to pursue (or not) a particu-
lar treatment. Method: As with Phase 2, focused interviews
will be conducted on a one-to-one basis with patients in a
location convenient to them. GDPs from Phase 2 will be
asked to identify patients who fulfil the inclusion criteria
and to send these people an information pack about the
study. This information pack will contain a study infor-
mation sheet, a consent to contact form and a reply paid
envelope for the return of the form to the study research
team. This design means that no patient information will
need to be released by the dentist to the study research
team. No reminders will be used. Patients who choose to
return a consent to contact form will be contacted by a
study researcher and given an opportunity to further dis-
cuss their potential involvement in a study interview. If
the patient verbally agrees to participate in an interview,
patients will be given a choice of venue and offered an
interview time that suits them. Written informed consent
will be obtained at the time of but prior to the patient
interview.
Data Preparation and Analysis for Phases 2 and 3
All interviews will be digitally recorded and transcribed
verbatim. In line with Data Protection Legislation and
Research Governance all information pertaining to indi-
viduals will be anonymised. Data collection and analysis
will occur concurrently to allow for issues which arise in
earlier interviews in a particular phase of the study to be
explored in more depth in subsequent interviews in that
phase. Thematic analysis, based on the 'constant compar-
ative method' [28,29] will be employed. The validity of
data interpretation will be ensured by independent cod-
ing and cross-checking by at least two members of the
research team. A suitable software package (e.g. NVivo)
will be used to facilitate the management of data analysis.
The study team includes social scientists (CE, NR); den-
tists (JS, JE, JF, MT); psychologists (TF) and health econo-
mists (CD). Regular team meetings and data sessions
throughout the data collection and analysis period will
ensure we maximise the benefit to the study of these
diverse perspectives.
Conceptual analytic framework
In order to deliver the objectives of the study, in the anal-
ysis of data from Phases 2 & 3 the following conceptual
framework will be applied to ascertain how decisions
about clinical need and treatment decisions are mediated
by different social, psychological, clinical and financial
factors. Each of these concepts relates directly to the objec-
tives of the study and will form the basis for a robust con-
ceptual model.
1. Affect – how do issues of self-perception and self-
esteem affect how clinical need is negotiated, and which
treatment decisions are made? (Objectives 1,2)
2. Conceptualisation – how does the lived experience
affect decision making (e.g. functionality, quality of life)
affect how clinical need is negotiated, and which treat-
ment decisions are made? (Objectives 1,2)
3. Life-world – how do personal relationships (e.g. family,
friends), socioeconomic circumstances, and interactions
within the patient's life world affect the decision making
process? (Objectives 3,4)
4. Clinical world – how do interactions within the clinical
setting (e.g. Practitioner advice; knowledge of treatment;
availability of treatment) affect decisions? (Objectives
3,4)
Ethical approval
This study has approval from Sunderland NHS Local
Research Ethics Committee (Ref:06/Q0904/25), and NHS
R&D approval from each participating site. Those in direct
contact with patients have been issued with honorary
NHS contracts. The study has been the subject of an NHS
R&D research governance audit.
There are no particular ethical problems with this study.
The main issue relates to maintaining confidentiality of
participant data, which will be collected and held in
accordance with the Data Protection Act, 1998, and the
requirements of NHS research governance. Recruitment of
patients will be carried out by their dentists on an "opt-in"
basis. Care will be taken to ensure that individual partici-
pants are not identifiable in any published outputs from
the study.
Discussion
Prior to this study, there was a lack of information availa-
ble about the scope of dental implant treatment in the UK.
Thus we designed this study on the basis of limited infor-
mation and some of our preconceptions proved different
from the situation found in practice. Three differences
that impacted on phase 3 are discussed here:
1. It became apparent after the study started that ISOD
treatment was unusual in primary care, at least in our
study area; most patients with missing teeth who paid forPage 6 of 8
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extended our sampling criteria for phase 3 to include
patients with other types of implant supported restora-
tion, although we continued to exclude patients who had
considered a straight forward single tooth replacement.
2. We also found that, because secondary care (NHS) den-
tal implant treatment is only "offered" to a small number
of people with severe problems with denture tolerance,
that there were very few people who turned down this
treatment if offered. This meant that the numbers of peo-
ple available to recruit to the study (the "refuse implants"
box in the secondary care column of table 1) was very
small. Findings from a previous study[30] suggested that
some patients will turn down the opportunity for dental
implant treatment even when there is no cost to them-
selves. However that study was carried out in the context
of a trial which included people who were not experienc-
ing significant problems with their existing conventional
dentures. This represents a very different patient popula-
tion to those seen in UK secondary care.
3. Implicit in the design of the study was the idea that
most patients would be offered implant treatment by their
usual GDP who would either perform the treatment
themselves or refer the patient to another GDP. In prac-
tice, we have found a high level of self referral by patients
to implant providers.
Conclusion
Both the dental consultation and private health care rep-
resent neglected areas of research. This study offers the
opportunity to develop an empirical, theoretical and prac-
tical understanding of the dynamics of treatment
resources, patient preferences and decision making proc-
esses for treatments which incur a personal financial cost.
It will have wider general applicability to an increasing
number of other areas of service provision where patients
may be required to make a decision about paying for treat-
ments. The study will provide information about the
likely demand for health care treatments and services
which incur a personal cost to patients and the trade-offs
patients are prepared to make in order to achieve their
desired outcome when they are faced with the fact that
they have to make a personal financial contribution. This
study also has relevance to the broader debate on tackling
health inequalities by examining the extent to which
mediating factors such as patient payment distort the
alignment of health care provision with clinical need.
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